The Nevakar Story

The word Nevakar means ‘new form’ and has it's roots in the Sanskrit language.

We strive to create new products from existing molecules with a value proposition to address meaningful unmet needs.

Our History

Founded in 2015 by Dr. Navneet Puri, Nevakar’s vision is to establish a sustainable and scalable novel product differentiation approach targeted to address unmet clinical and commercial needs for established molecules. Since its founding, Nevakar has evolved greatly as a company, while maintaining a strong commitment about our patients and effective drug delivery.

five short years
many major milestones

10 Employees
6 Product candidates
$55mm Capital raised
0 Partnered products
2 Patents filed
0 NDAs filed
70 Employees
13 Product candidates
$195mm Capital raised
5 Partnered products
48/21 Patents filed/granted
3 NDAs filed
COVID-19 vaccine development
Interested in discussing potential partnerships, Contact Us
We are always scanning for future opportunities

driven by our values


At Nevakar, our goal is to deliver real value to patients by offering high quality, innovative and accessible products which lead to clinically meaningful outcomes.

Due to our proprietary enhancement and repositioning approach, many of our new products are patent-protected and filed with the FDA primarily utilizing the 505(b)(2) regulatory pathway.